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Abstract
Auberle social services is opening the Family Healing Center (FHC), a level 3.5 treatment program in
Pittsburgh, PA that provides housing and 24-hour support for families struggling with opioid addiction.
We partnered with Auberle to study characteristics of individuals receiving level 3.5 treatment and to
determine whether longer treatment lengths correlate with fewer adverse outcomes.
We obtained data from the Allegheny County Department of Human Services on 2,016 individuals
admitted to level 3.5 treatment in 2019. The data included birth year, race, gender, admittance date, discharge date, and Children Youth and Family (CYF) incidents before and after treatment. We categorized
the population into three groups based on length of treatment (<14, 14-30, and 30+ days). We applied
statistical tests to determine significant demographic differences between the groups. Additionally, we
measured the impact of treatment in each group by examining the change in CYF incidents before and
after treatment.
Results show that the average age of individuals in each group increased with treatment length. The
group that persisted in treatment 30+ days contained a higher percentage of Black/African American
individuals (33%) than the other two groups (22-23%). We found that the frequency of CYF cases
decreased after treatment across all groups, with the largest decrease observed in the group with 30+
days of treatment. Additionally, we observed that the frequency of CYF placements after treatment
decreased as treatment length increased.
These results will help Auberle better understand characteristics of individuals served by the FHC
and demonstrate the positive impact of persistence in a treatment program.
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Background
Since the 1990s, the opioid epidemic has negatively impacted the United States. Responses to this

conflict naturally focus on directly treating individuals with Substance Use Disorders (SUDs). However,
there is considerably less professional attention toward restructuring family dynamics of caregivers with
SUDs even when the family experiences adverse effects [1]. In 2017 alone, 2.2 million children were affected
by the opioid epidemic in the United States [3]. As seen in Figure 1, the prevalence of parental alcohol or
drug use as an identified condition of a child’s home removal has risen 20.4% in the past two decades [4].
Among the state of Pennsylvania’s child removals, 32.4% were SUD-associated in 2019, well surpassing
the national average at the time [4]. The rate of opioid deaths in Allegheny County alone has continually
grown over 15% from 2018-2020 [5]. This statistic coupled with the lack of support for families affected by
SUDs has prompted the Pennsylvania Department of Drug and Alcohol Abuse to promote and prioritize the
development of family-centered SUD treatment [6].
Auberle, a nonprofit social services organization located in Pittsburgh, Pennsylvania, has developed a
driven team actively responding to this pressing request. With a mission of providing positive outcomes
for strong individuals, families, and communities, Auberle’s trauma-informed care programs cover a deep
myriad of services, including teen youth and foster care, housing, behavioral health services, and employment
services [7].
Currently, Auberle is preparing to open the Family Healing Center (FHC) in June of 2022. Located in
Mount Oliver, this facility hopes to diminish the likelihood of childrens’ separation from their families due
to SUDs. Specifically, the FHC will admit families with a caregiver qualifying for level 3.5 treatment for
opioid addiction. In Pennsylvania, level 3.5 treatment is an intense, regulated level of care without hospital
admittance. Typical 3.5 treatment includes a certified recovery specialist as well as a counselor or therapist.
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Figure 1: Growing rate of SUD-related child removals from 2010-2019 [4]
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In addition to these services, the FHC will also provide a family support specialist, onsite childcare services,
evidence-based parent support programs, and even transportation services for families. Auberle considers a
family member as any individual residing in the same home as the admitted adult. Further, the FHC will
consider any individual between the ages of 0 and 18 as a child. The FHC will accept up to and including
4 children for each family. Therein, these generalizations for admittance are unique facets of the FHC that
remove common barriers for families in need.
As previously mentioned, the FHC aims to treat caregivers with SUDs and simultaneously strengthen
family structures so children are safe remaining in their homes following treatment. In other words, the
FHC would like to diminish the occurrence of Children, Youth, and Family (CYF) incidents in Southwestern
Pennsylvania. Throughout this project, CYF incidents are distinguished using the following terminology:
• A CYF case entails an active, open case following alleged reports, claims, or alarming instances that
give rise to further investigation.
• A CYF placement is more severe and may result in a child’s removal from his or her home prior to
placement into foster or relative care.
In our project, we explore the impact of level 3.5 treatment programs on both CYF cases and placements.
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Project Objective
This study examines the demographics of individuals with SUDs who received level 3.5 treatment in

Allegheny County in 2019. We divided the population into three groups based on length of time in treatment
and compared demographics across these groups to identify key characteristics of those who persisted in
treatment. Finally, we measured the impact of level 3.5 treatment on CYF cases and placements and
evaluated how these measures differ based on treatment length.
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Methodology

3.1

Data

We obtained data from the Allegheny County Department of Human Services on 2,016 individuals who
received level 3.5 treatment in Allegheny County in 2019. This data included the following information for
each individual:
• Birth year
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• Race
• Gender
• Date on which the individual was admitted into treatment
• Date on which the individual was discharged from treatment
Using the data, we calculated the following information for each individual:
• Age, and
• Length of treatment (i.e., length of time between admittance and discharge dates).
Individuals in our population were categorized into one of three treatment groups based on length of
treatment. The groups were defined as less than 14 days in treatment, 14 to 30 days in treatment, and more
than 30 days in treatment. These categorizations were determined based on discussions with Auberle and
further investigations of the data set. Specifically, treatment lengths less than 14 days were indicative of
a failed treatment program. The shortest level 3.5 treatment program is 14 days, but many programs can
exceed 4-6 months. Figure 2 displays the frequency of treatment lengths among our population. There is
a considerable drop in number of individuals who persisted in treatment beyond 30 days, thus we opted to
place these individuals into a single group.

Frequency

Treatment Length

Treatment (days)

Figure 2: Histogram showing the distribution of treatment lengths within our population. The population
was divided into three treatment groups based on treatment length: < 14 days (green bar), 14–30 days
(orange bar), 30+ days (purple bars).
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3.2

Procedures

First, we applied statistical tests to determine if there were significant differences in race, gender, and age
across the three treatment groups. All tests resulting in p < 0.05 were considered statistically significant.
All statistical tests were implemented using statistical software R. [2]
Chi-squared tests were used to evaluate differences in race and gender, non-continuous variables, across
the three groups. Chi-squared test values were obtained in R using the chisq.test() function and the formula

χ2 =

X (Oi − Ei )2
Ei

where Ei is the expected value and Oi is the observed value. After performing the Chi-squared tests, variables
resulting in significant p-values were further analyzed. Specifically, additional Chi-squared tests were applied
pairwise to the groups to determine statistical significance in race and gender. The Bonferroni correction
was used in this step to account for multiple comparisons being executed. The Bonferroni corrected p-value
is calculated by dividing the original p-value by the number of analyses on the dependent variable.
One-way analysis of variance (ANOVA) test was performed to evaluate differences in age, a continuous
variable, across the three treatment groups. Within R, the ANOVA test was applied using the hypotheses

H0 : µ1 = µ2 = µ3
H1 : at least one population mean is different from the rest.

The F-value for the ANOVA test was obtained in R using

F =

M SR
M SE

where MSR represents the regression mean square and MSE represents the Error Mean Square.
Second, we evaluated the impact of treatment on CYF cases by comparing the percentage of individuals
with a CYF case before treatment to the percentage of individuals with a CYF cases after treatment. The
same was done with CYF placements. These percentages were graphed and we compared the results across
the three treatment groups.
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Results

4.1

Demographic Summary of Population

Our population consisted of 2,016 individuals who received level 3.5 treatment in Allegheny County
in 2019. We found that the majority (1,351 individuals, 67%) of this population was male (Figure 3).
Furthermore, approximately 75% of the population was White (1,525 individuals) and 24% (477 individuals)
was Black/African American. Less than 1% (14 individuals) of the population that were identified as
Other/No Data (Figure 4). The age of individuals within our population ranged from 16 to 77 years with a
mean age of 40.25 years. The highest frequency of age values was between 30-40 years (Figure 5).

Gender

Female
33%

Male
67%
Figure 3: Pie chart summarizing the gender of individuals who received level 3.5 treatment in 2019

Race
White
75%

Other/No Data
1%

Black/African American 24%

Figure 4: Pie chart summarizing the race of individuals who received level 3.5 treatment in 2019
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Age

Frequency

Min Age: 16
Max Age: 77
Mean Age: 40.25

Age (Years)

Figure 5: Histogram displaying the distribution of ages of individuals who received level 3.5 treatment in
2019

4.2

Demographic Differences across Treatment Groups

Upon dividing our population into three treatment groups, we found 945 (46.9%) individuals did not
persist in treatment beyond 14 days. Additionally, we found 921 (45.68%) individuals remained in treatment
between 14 to 30 days, and the remaining 150 (7.44%) spent 30 or more days in treatment.
Results from the statistical analyses of race, age, and gender across all three treatment groups are
displayed in Table 1. There were statistically significant differences in race and age across the treatment
groups (p < 0.05). Post-hoc tests revealed a significantly higher percentage of Black/African American
individuals in the 30+ treatment group compared to the other two groups. Age increased as treatment
length increased; therefore, on average, older individuals were more likely to remain in treatment beyond 30
days. Gender did not vary significantly across the three groups.

Variable
Race [%]
White
Black/African American
Other/No Data
Age [mean, (sd)]
Gender [%]
Male
Female

<14 days
(n = 945)

14-30
days
(n = 921)

30+ days
(n = 150)

Significance
Test

p value

75.76
23.17
1.06

76.98
22.58
0.43

66.66
33.33
0

χ2 = 12.034

0.0171

39.42
(10.16)

40.97
(11.09)

41.07
(11.27)

F = 5.348

0.00483

66.88
33.12

66.45
33.55

71.33
28.66

χ2 = 1.4066

0.4949

Table 1: Comparison of demographics across treatment groups
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4.3

Impact of Treatment on CYF Cases

We found that longer treatment lengths corresponded to decreased rates of CYF cases and placements.
Figure 6 illustrates the change in the percentage of individuals with a CYF cases before and after treatment
for each of the treatment groups. All treatment groups experienced a decrease in CYF cases after treatment
compared to before treatment; however, the largest decrease in percentage values occurred in the 30+ days
group. Among individuals who spent more than 30 days in treatment, the percentage of individuals with a
CYF case after treatment dropped 2.67% (12.67% pre-treatment to 10% post-treatment).
Additional focus was placed on the subset of individuals in our population with a CYF case prior to
treatment. Figure 7 shows that among these individuals, the rate of CYF cases after treatment decreased
across all groups. Notably, the group with 30+ days in treatment experienced the smallest rate of CYF cases
after treatment.

4.4

Impact of Treatment on CYF Placements

As we continued to focus on the subset of individuals in our population with a CYF case prior to
treatment, we found similar results related to CYF placements. Figure 8 shows that among this subset of
the population, the rate of CYF placements after treatment decreased as treatment length increased. Similar
to our earlier results, the group with the lowest rate of CYF placements after treatment was the group with
30+ days in treatment.

% of individuals with Cases

<14
[14,30]
30+

Post Treatment

Pre- Treatment

Figure 6: Percent of individuals with a documented CYF case pre and post treatment
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% of Individual with Post-Discharge
Case given Pre- Treatment Case

<14
[14,30]
30+
Treatment Length (days)

% of Individuals with Post-Discharge
Placement given Pre- Treatment Case

Figure 7: Percent of cases following treatment among subset of individuals with a pre-treatment CYF Case

30+
<14
[14,30]
Treatment Length (days)

Figure 8: Percent of placements following treatment among subset of individuals with a pre-treatment CYF
Case
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Concluding Remarks
In summary, our results revealed that the individuals who used level 3.5 treatment in Allegheny County

in 2019 were predominately male and predominately white. The average age of individuals in this population
was 40 years. However, after analyzing the length of time these individuals spent in treatment, we found
that individuals who persisted in treatment beyond 30 days are on average older and more likely to be
Black/African American than those in shorter treatment programs.
Our results also revealed that individuals who persisted in treatment beyond 30 days consistently experienced fewer adverse outcomes related to CYF cases and placements. Specifically, the largest decrease in
the percentage of individuals with a CYF case before versus after treatment was observed in the treatment
group that persisted beyond 30 days. Further analyses focusing on only individuals with a CYF case before
treatment showed reduced rates of CYF cases and placements after treatment in all groups. However, the
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largest decrease was again observed in the group that persisted in treatment beyond 30 days.
A limitation of our study is that the data on each individual’s CYF history was restricted to the one-year
period before and after treatment. While this limitation has no impact on the outcome of this research,
future work could seek the long term (>1 year) impact of level 3.5 treatment on families.
The results of this study will help Auberle better understand the demographic characteristics of individuals served by the FHC, and also demonstrate the positive impact of persistence in a treatment program.
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